Formulary Search Results for: beclometasone
12.2.1 Drugs used in nasal allergy - View Category
3.2.1 Single agent inhaled devices - View Category
Prescribing Notes:
To prevent confusion, prescribe inhaler devices by brand name. Different brands of beclometasone CFC-free inhalers are not equipotent and should be prescribed by brand name for safety reasons.
3.2.1 Single agent inhaled devices - View Category
Prescribing Notes:
Preferred brands and devices:
- Beclometasone Easyhaler® (DPI)
- Clenil Modulite® (MDI)
To prevent confusion, prescribe inhaler devices by brand name. Different brands of beclometasone CFC-free inhalers are not equipotent and should be prescribed by brand name for safety reasons.
3.2.2 Combination inhaled devices - View Category
Restrictions:
Asthma: Refer to NHSGGC Inhaler Device Guide for place in therapy in adults.
COPD: Use of the 100/6 strength for the treatment of severe COPD is restricted to use in accordance with the current NHSGGC COPD Inhaler Device Guide.
Prescribing Notes:
Preferred brand and devices:
- Fostair NEXTHaler® (dry powder inhaler)
- Luforbec® (aerosol inhaler)
To prevent confusion, prescribe inhaler devices by brand name.
In selected adult patients with asthma, the use of beclometasone and formoterol 100/6 in a single inhaler as rescue medication instead of a short-acting beta2 agonist, in addition to its regular use as controller therapy, has been shown to be an effective treatment regime.
Fostair 200/6 and Luforbec 200/6 strength aerosol inhaler are not currently licensed for use in COPD or for the maintenance and relief use in asthma (as described in the paragraph above).